Rat mesangial α-endosulfine

Kidney International

Volumn 65, Issue 5, 2004, Pages 1731-1739

  Yee, Jerry ^a   Cortes, Pedro ^b   Barnes, Jeffrey L ^b   Alviani, Rebecca ^b   Biederman, Jason I ^b   Szamosfalvi, Balázs ^b  

^a HENRY FORD HOSPITAL   (United States)

^b NONE

Author keywords

ATP sensitive K+ channel (KATP); Cell contractility; Mesangial cell; Sulfonylurea receptor (SUR); endosulfine

Indexed keywords

ALPHA ENDOSULFINE; SULFONYLUREA DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; CONFERENCE PAPER; CONFOCAL MICROSCOPY; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENETIC CODE; GENETIC TRANSCRIPTION; GLOMERULUS FILTRATION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IN SITU HYBRIDIZATION; KIDNEY CORTEX; MALE; MESANGIUM CELL; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 2342595788     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00578.x     Document Type: Conference Paper

References (45)

1. ATP channels. Diabetes 45:1439-1445, 1996
2. BEESLEY AH, QURESHI IZ, GIESBERTS AN, et al: Expression of sulfonylurea receptor protein in mouse kidney. Pflügers Arch 438:1-7, 1999
3. CORTES P, RISER BL, ASANO K, et al: Effects of oral antihyperglycemic agents on extracellular matrix synthesis by mesangial cells. Kidney Int 54:1985-1998, 1998
4. ASANO K, CORTES P, GARVIN JL, et al: Characterization of the rat mesangial cell type 2 sulfonylurea receptor. Kidney Int 55:2289-2298, 1999
5. + channel. Kidney Int 61:1739-1749, 2002
6. ATP channels. Physiol Rev 78:227-245, 1998
7. ATP channels. Annu Rev Physiol 60:667-687, 1998
8. VIRSOLVY-VERGINE A, LERAY H, KUKORI S, et al: Endosulfine, an endogenous peptidic ligand for the sulfonylurea receptor: Purification and partial characterization from ovine brain. Proc Natl Acad Sci USA 89:6629-6633, 1992
9. VIRSOLVY-VERGINE A, SALAZAR G, SILLARD R, et al: Endosulfine, endogenous ligand for the sulphonylurea receptor: Isolation from porcine brain and partial structural determination of the alpha form. Diabetologia 39:135-141, 1996
10. PEYROLLIER K, HÉRON L, VIRSOLVY-VERGINE A, et al: Alpha endosulfine is a novel molecule, structurally related to a family of phosphoproteins. Biochem Biophys Res Comm 223:583-586, 1996
11. ATP channels. Diabetes 48:1873-1876, 1999
12. ATP channel: Molecular cloning, expression and biological properties. Proc Natl Acad Sci USA 95:8387-8391, 1998
13. BATAILLE D, HÉRON L, VIRSOLVY A, et al: Alpha-endosulfine, a new entity in the control of insulin secretion. Cell Mol Life Sci 56:78-84, 1999
14. KANG S-W, ADLER SG, NAST CC, et al: 12-lipoxygenase is increased in glucose-stimulated mesangial cells and in experimental diabetic nephropathy. Kidney Int 59:1354-1362, 2001
15. BARNES JL, TORRES ES, MITCHELL RJ, et al: Expression of alternatively spliced fibronectin variants during remodeling in proliferative glomerulonephritis. Am J Pathol 147:1361-1371, 1995
16. CORTES P, MENDEZ M, RISER BL, et al: F-actin fiber distribution in glomerular cells and functional implications. Kidney Int 58:2452-2461, 2000
17. BATAILLE D: Endosulfines: Novel regulators of insulin secretion. Drug News Perspect 13:453-462, 2000
18. DULUBOVA I, HORIUCHI A, SNYDER GL, et al: ARPP-16/ARPP-19: A highly conserved family of cAMP-regulated phosphoproteins. J Neurochem 77:229-238, 2001
19. HEMMINGS HC JR, GIRAULT JA, WILLIAMS KR, et al: ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions: Amino acid sequences of the site phosphorylated by cyclic AMP in intact cells, and kinetic studies of its phosphorylation in vitro. J Biol Chem 264:7726-7733, 1989
20. KURIHARA T, EHRLICH ME, HORIUCHI J, et al: ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. II. Molecular cloning and nucleotide sequence. J Neurosci 9:3638-3644, 1989
21. GIRAULT J, HORIUCHI A, GUSTAFSON E, et al. Differential expression of ARPP-16 and ARPP-19, two highly related cAMP-regulated phosphoproteins, one of which is specifically associated with dopamine-innervated brain regions. J Neurosci 10:1124-1133, 1990
22. GIRAULT JA, WALAAS SI, HEMMINGS HC JR, et al: ARPP-21, a cAMP-regulated phosphoprotein enriched in dopamine-innervated brain regions: Tissue distribution and regulation of phosphorylation in rat brain. Neuroscience 37:317-325, 1990
23. HORIUCHI A, WILLIAMS KR, KURIHARA T: Purification and cDNA cloning of ARPP-16, a cAMP-regulated phosphoprotein enriched in basal ganglia, and a related phosphoprotein, ARPP-19. J Biol Chem 265:9476-9484, 1990
24. BRENE S, LINDEFORS N, EHRLICH M, et al: Expression of mRNAs encoding ARPP-16/19, ARPP-21, and DARPP-32 in human brain tissue. J Neurosci 14:985-998, 1994
25. BAKHEET T, FREVEL M, WILLIAMS BRG, et al: ARED: Human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins. Nucleic Acids Res 29:246-254, 2001
26. GROS L, BRÉANT B, DUCHENNE B, et al: Localization of alpha-endosulphine in pancreatic somatostatin delta cells and expression during rat pancreas development. Diabetologia 45:703-710, 2002
27. IRWIN N, CHAO S, GORITCHENKO L, et al: Nerve growth factor controls GAP-43 mRNA stability via the phosphoprotein ARPP-19. Proc Natl Acad Sci USA 99:12427-12431, 2002
28. KIM SH, LUBEC G: Brain alpha-endosulfine is manifold decreased in brains from patients with Alzheimer's disease: A tentative marker and drug target? Neurosci Lett 310:77-80, 2001
29. KIM SH, LUBEC G: Decreased alpha-endosulfine, an endogenous regulator of ATP-sensitive potassium channels, in brains from adult Down syndrome patients. J Neural Trans (Suppl) 61:1-9, 2001
30. NISHI A, SNYDER GL, GREENGARD P: Bidirectional regulation of DARPP-32 phosphorylation by dopamine. J Neurosci 17:8147-8155, 1997
31. ATP channel as a receptor for potassium channel openers. J Biol Chem 271:8796-8799, 1996
32. + channels in mitochondria. Biochem Biophys Res Comm 241:693-697, 1997
33. ATP channels of the endocrine pancreas. Diabetes 52:767-776, 2003
34. ATP channels in cardioprotection against ischemia/reperfusion injury in mice. J Clin Invest 109:509-516, 2002
35. 3H-glibenclamide in pancreatic islet cells. Diabetologia 29:259-261, 1996
36. SCHWANSTECHER M, SCHWANSTECHER C, DICKEL C, et al: Location of the sulfonylurea receptor at the cytoplasmic face of the beta-cell membrane. Brit J Pharmacol 113:903-911, 1994
37. WHITESIDE CI, HURST RD, STEVANOVIC ZS: Calcium signaling and contractile response of diabetic glomerular mesangial cells. Kidney Int 48(Suppl 51):S28-S33, 1995
38. BANK N: Mechanisms of diabetic hyperfiltration. Kidney Int 40:792-807, 1991
39. CORTES P, RISER BL, ZHAO X, NARINS RG: Glomerular volume expansion and mesangial cell mechanical strain: Mediators of glomerular pressure injury. Kidney Int 45 (Suppl 45):S11-S16, 1994
40. CORTES P, RISER BL: The nature of the glomerulus: Pressure-induced metabolic alterations, in The Kidney and Hypertension in Diabetes Mellitus, edited by Mogenson CE, Boston, Kluwer, 1996, pp 119-124
41. CORTES P, YEE J: Potentiation of glucose-mediated glomerular injury by mechanical strain. Clin Exper Pharmacol Physiol 29:149-152, 2002
42. RIENECK K, BOVIN LF, JOSEFSEN K, et al: Massive parallel gene expression profiling of RINm5F pancreatic islet beta-cells stimulated with interleukin-1 beta. APMIS 108:855-872, 2000
43. COOPER DR, VILA MC, WATSON JE, et al: Sulfonylurea-stimulated glucose transport association with diacylglycerol-like activation of protein kinase C in BC3H1 myocytes. Diabetes 39:1399-1407, 1990
44. MULLER G, WIED S: The sulfonylurea drug, glimepiride, stimulates glucose transport, glucose transporter translocation, and dephosphorylation in insulin-resistant rat adipocytes in vitro. Diabetes 42:1852-1867, 1993
45. ECKEL J: Direct effects of glimepiride on protein expression of cardiac glucose transporters. Hormone Met Res 28:508-511, 1996